Fayez Sarofim & Co’s CME Group CME Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $342M | Sell |
1,241,430
-29,452
| -2% | -$8.12M | 0.82% | 36 |
|
|
2025
Q1 | $337M | Sell |
1,270,882
-252,554
| -17% | -$67M | 0.84% | 39 |
|
|
2024
Q4 | $354M | Buy |
1,523,436
+53,389
| +4% | +$12.4M | 0.86% | 33 |
|
|
2024
Q3 | $324M | Buy |
1,470,047
+105,960
| +8% | +$23.4M | 0.82% | 37 |
|
|
2024
Q2 | $268M | Buy |
1,364,087
+225,024
| +20% | +$44.2M | 0.72% | 40 |
|
|
2024
Q1 | $245M | Buy |
1,139,063
+31,594
| +3% | +$6.8M | 0.73% | 41 |
|
|
2023
Q4 | $227M | Buy |
1,107,469
+356,423
| +47% | +$73.1M | 0.69% | 41 |
|
|
2023
Q3 | $150M | Buy |
751,046
+315,668
| +73% | +$63.2M | 0.51% | 51 |
|
|
2023
Q2 | $80.7M | Buy |
435,378
+246,820
| +131% | +$45.7M | 0.28% | 61 |
|
|
2023
Q1 | $36.1M | Buy |
188,558
+162,535
| +625% | +$31.1M | 0.13% | 74 |
|
|
2022
Q4 | $4.38M | Buy |
26,023
+6,760
| +35% | +$1.14M | 0.02% | 111 |
|
|
2022
Q3 | $3.41M | Buy |
19,263
+525
| +3% | +$93K | 0.01% | 119 |
|
|
2022
Q2 | $3.84M | Buy |
18,738
+1,203
| +7% | +$246K | 0.01% | 122 |
|
|
2022
Q1 | $4.17M | Buy |
17,535
+12,396
| +241% | +$2.95M | 0.01% | 128 |
|
|
2021
Q4 | $1.17M | Buy |
5,139
+413
| +9% | +$94.3K | ﹤0.01% | 197 |
|
|
2021
Q3 | $914K | Buy |
4,726
+68
| +1% | +$13.2K | ﹤0.01% | 199 |
|
|
2021
Q2 | $991K | Buy |
4,658
+1,063
| +30% | +$226K | ﹤0.01% | 208 |
|
|
2021
Q1 | $734K | Buy |
3,595
+25
| +0.7% | +$5.1K | ﹤0.01% | 198 |
|
|
2020
Q4 | $650K | Buy |
3,570
+100
| +3% | +$18.2K | ﹤0.01% | 195 |
|
|
2020
Q3 | $581K | Buy |
3,470
+250
| +8% | +$41.9K | ﹤0.01% | 189 |
|
|
2020
Q2 | $523K | Buy |
3,220
+1,245
| +63% | +$202K | ﹤0.01% | 188 |
|
|
2020
Q1 | $341K | Buy |
+1,975
| New | +$341K | ﹤0.01% | 200 |
|